Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Shunde Medi-World Pharmaceutical is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of China Medical System Holdings (CMS). Located in the Shunde District of Foshan, the company operates advanced production lines for tablets, capsules, and granules, all maintaining strict GMP compliance. Its business model integrates internal R&D with large-scale manufacturing to support a diverse portfolio of treatments for gastrointestinal, cardiovascular, and central nervous system disorders. Medi-World serves as a vital production hub for CMS, facilitating the commercialization of both self-developed drugs and licensed products within the Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Shunde Medi-World Pharmaceutical.